top of page
    • Jan 4, 2023

Divestment

Scope law advises an institutional investor in its divestment in connection with Biognosys AG’s strategic partnership with Bruker Corporation.


Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a majority-ownership investment in the ETH spin-off Biognosys. Financial details were not disclosed. Scope law’s client has, together with other investors, sold its shares to Bruker in a secondary transaction, and Bruker will make new primary investments in Biognosys.


Recent Posts

See All

Financing Round

Scope Law advises Crearene AG , Frauenfeld, Switzerland on further equity financing. Crearene, an innovative medical technology company...

M&A Transaction

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A.  (Greece) on its sale to Rosemont Pharmaceuticals Ltd....

M&A Transaction

Scope Law advised Expat Payroll AG, Zurich on the acquisition of a business division from KRESTON ZURICH AG, Zurich by way of a transfer...

Comentários

bottom of page